Esophageal and gastric cancer incidence trends in Golestan, Iran: An age‐period‐cohort analysis 2004 to 2018

Author:

Ghasemi‐Kebria Fatemeh1,Semnani Shahryar1,Fazel Abdolreza2,Etemadi Arash3ORCID,Amiriani Taghi1,Naeimi‐Tabiei Mohammad2,Hasanpour‐Heidari Susan1,Salamat Faezeh1,Jafari‐Delouie Nastaran1,Sedaghat SeyyedMehdi4,Sadeghzadeh Hamideh4,Akbari Mahnaz5,Mehrjerdian Mahshid6,Weiderpass Elisabete7,Roshandel Gholamreza1ORCID,Bray Freddie8,Malekzadeh Reza9

Affiliation:

1. Golestan Research Center of Gastroenterology and Hepatology Golestan University of Medical Sciences Gorgan Iran

2. Cancer Research Center Golestan University of Medical Sciences Gorgan Iran

3. Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland USA

4. Deputy of Public Health Golestan University of Medical Sciences Gorgan Iran

5. Deputy of Treatment Golestan University of Medical Sciences Gorgan Iran

6. Department of Pathology Golestan University of Medical Sciences Gorgan Iran

7. Office of the Director International Agency for Research on Cancer (IARC) Lyon France

8. Cancer Surveillance Branch International Agency for Research on Cancer (IARC), World Health Organization (WHO) Lyon France

9. Digestive Oncology Research Center, Digestive Diseases Research Center Tehran University of Medical Sciences Tehran Iran

Abstract

AbstractGolestan province in the northeast of Iran is part of the Asian esophageal cancer belt and is known as a high‐risk area for esophageal (EC) and gastric cancers (GC). Data on incident cases of EC and GC during 2004 to 2018 were obtained from the Golestan Population‐based Cancer Registry (GPCR). The age‐standardized incidence rates (ASRs) were calculated and presented per 100 000 person‐years. The estimated annual percentage change (EAPC) with 95% confidence interval (95% CI) were calculated. We also fitted age‐period‐cohort (APC) models to assess nonlinear period and cohort effects as incidence rate ratios (IRRs). Overall, 3004 new cases of EC (ASR = 15.7) and 3553 cases of GC (ASR = 18.3) were registered in the GPCR. We found significant decreasing trends in incidence rates of EC (EAPC = −5.0; 95% CI: −7.8 to −2.2) and less marked nonsignificant trends for GC (EAPC = −1.4; 95% CI: −4.0 to 1.4) during 2004 to 2018. There was a strong cohort effect for EC with a consistent decrease in the IRR across successive birth cohorts, starting with the oldest birth cohort (1924; IRR = 1.9 vs the reference birth cohort of 1947) through to the most recent cohort born in 1988 (IRR = 0.1). The marked declines in EC incidence rates in Golestan relate to generational changes in its underlying risk factors. Despite favorable trends, this population remains at high risk of both EC and GC. Further studies are warranted to measure the impact of the major risk factors on incidence with a view to designing effective preventative programs.

Funder

Golestan University of Medical Sciences

Publisher

Wiley

Subject

Cancer Research,Oncology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3